» Articles » PMID: 31009281

Identification and Management of Lymphedema in Patients With Breast Cancer

Overview
Journal J Oncol Pract
Specialty Oncology
Date 2019 Apr 23
PMID 31009281
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Breast cancer-related lymphedema (BCRL) is a potentially debilitating and often irreversible complication of breast cancer treatment. Risk of BCRL is proportional to the extent of axillary surgery and radiation. Other risk factors include obesity and infections. Given the 5-year survival rate of 90% and its potential impact on the quality of life of survivors of breast cancer, BCRL has become a significant financial burden on the health care system. Minimizing axillary surgery and radiation has been proven to reduce the risk of BCRL. Comprehensive multidisciplinary assessment at the time of initial diagnosis; early referral to physical therapy after surgery; and patient education regarding weight loss, skin, and nail care are cornerstones of the management of early-stage lymphedema. End-stage lymphedema may benefit from referral to a plastic surgeon specializing in lymphedema surgery. In this review, we attempt to review the incidence, risk factors, staging, prevention, and management of this complication of breast cancer treatment. We also describe our multidisciplinary approach for the prevention of this complication at the time of initial diagnosis.

Citing Articles

Current diagnostic and quantitative techniques in the field of lymphedema management: a critical review.

Vargo M, Aldrich M, Donahue P, Iker E, Koelmeyer L, Crescenzi R Med Oncol. 2024; 41(10):241.

PMID: 39235664 PMC: 11377676. DOI: 10.1007/s12032-024-02472-9.


Lymphedema after regional nodal irradiation for breast cancer: a retrospective cohort study.

Park J, Kim Y, Kim H, Choi Y Ann Surg Treat Res. 2024; 106(6):337-343.

PMID: 38868589 PMC: 11164658. DOI: 10.4174/astr.2024.106.6.337.


Breast cancer survivors suffering from lymphedema: What really do affect to corporeality/body image? A qualitative study.

Gonzalez-Fernandez L, Romero-Morales C, Martinez-Pascual B, Rio-Gonzalez A, Cerezo-Tellez E, Lopez-Martin I Breast Cancer Res. 2024; 26(1):47.

PMID: 38486203 PMC: 10941543. DOI: 10.1186/s13058-024-01806-9.


Incidence of and Influencing Factors for Arm Lymphedema After Salvage Treatment for an Isolated Locoregional Recurrence of Breast Cancer.

Kim N, Kim H, Hwang J, Lee J, Park W, Cho W J Breast Cancer. 2023; 26(6):544-557.

PMID: 37985381 PMC: 10761755. DOI: 10.4048/jbc.2023.26.e43.


Etiology and treatment of cancer-related secondary lymphedema.

Bernas M, Al-Ghadban S, Thiadens S, Ashforth K, Lin W, Safa B Clin Exp Metastasis. 2023; 41(4):525-548.

PMID: 37777696 DOI: 10.1007/s10585-023-10232-8.